AxisOne combines artificial intelligence with milestone-based delivery to accelerate lab selection, tighten research execution, and close the accountability gap in global R&D collaboration.
iProcess Global Research Inc. today announced the launch of AxisOne (axisone.ai), an AI-powered platform the company calls the R&D operating system for the world. AxisOne consolidates lab discovery, feasibility assessment, milestone-based delivery, and project governance on a single platform, giving pharmaceutical, biotech, diagnostic, and academic organizations a direct line to qualified laboratories in more than 30 countries. The launch coincides with the AACR 2026 Annual Meeting in San Diego, where the iProcess team will be demonstrating the platform.
Finding the right laboratory partner for specialized testing still depends on personal networks, outdated directories, and manual vetting. For organizations working across life sciences, pharmaceutical, biotechnology, and diagnostic industries, the friction compounds: pricing is opaque, project oversight is inconsistent, and multi-site coordination adds layers of risk. The industry has outgrown these methods. AxisOne replaces them with a single intelligent platform that applies AI and structured workflows to accelerate feasibility, match researchers with the right labs, and govern the full project lifecycle from scoping through final deliverable.
AxisOne covers the full research lifecycle. At launch, its core capabilities include:
Additional AI capabilities are planned as the platform moves toward its longer-term goal: becoming the default operating layer for global R&D.
"AxisOne is the R&D operating system for the world," said Asker Ahmed, Executive Director of iProcess Global Research. "Placing R&D work with an external lab should be as structured and trackable as running it in-house. AxisOne gives researchers the tools to find the right lab, set clear milestones, and maintain full visibility from start to finish. As we expand the platform's AI capabilities, it will become the default infrastructure for how global R&D gets done."
AxisOne grows out of a mission iProcess has pursued for more than 22 years: making high-quality research more accessible. iProcess has supported pharmaceutical, biotech, and diagnostic companies through a global network of pre-qualified clinical sites across more than 30 countries, delivering ethically sourced, clinically annotated human biospecimens alongside integrated laboratory services. That operational depth, spanning sample handling, study execution, quality management, and cross-border logistics, now underpins AxisOne. The platform marks iProcess's shift into the digital era, applying an AI-first model to laboratory discovery and collaboration.
AxisOne is available now at axisone.ai. Organizations can learn more, schedule a demonstration, or register as a laboratory partner on the website, or contact iProcess Global Research directly.
iProcess Global Research Inc. is a global provider of biospecimens and laboratory services supporting biotech, pharma, diagnostics, and research organizations worldwide. Tagline: Leading the Future in Biospecimens, Testing, and Surveillance.
AxisOne is an AI-powered Global R&D Platform that helps life science organizations outsource experiments to world-class labs worldwide. AxisOne is built to streamline lab selection, reduce friction in project execution, and improve accountability through structured workflows and milestone-based delivery.
Forward-looking statement: This release may include plans and expectations regarding product capabilities and availability. Actual features and timelines may vary.